Drug intelligence / Profile preview

HL301

Development stage
Phase 3
Lead developer
Hanlim Pharm. Co., Ltd.
Modality
Small Molecules
Administration
Oral
01

Overview

HL301 is a combined product of seven medicinal plants formulated as an oral herbal medicine. It is developed primarily for the symptomatic treatment of acute bronchitis and has also been investigated for chronic obstructive pulmonary disease (COPD) and radiation pneumonitis in patients with unresectable non-small cell lung cancer. The precise mechanism of action remains undefined, but clinical studies have shown that it can improve symptoms such as cough, sputum production, dyspnea, and chest pain in acute bronchitis. In trials for radiation pneumonitis, it was found to be safe and tolerable but did not demonstrate efficacy at tested doses[1][2][8]. The product is classified under antibronchitics and traditional Chinese medicine.

Brand names
Bronpass Tab
Other names
HL301 herbal combinationHL-301 herbal combinationHL 301 herbal combination

Beyond the preview

Go deeper on HL301.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HL301.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call